title: Practice patterns of US neurologists in patients with CIS, RRMS, or RIS: A consensus study.
abstract: We assess current practice patterns of US neurologists in patients with clinically isolated syndrome (CIS), relapsing-remitting multiple sclerosis (RRMS), and radiologically isolated syndrome (RIS) using case-based surveys. For CIS, 87% recommended initiation of disease-modifying therapy (DMT) with MRI brain lesions. An injectable DMT was recommended by 90%-98% for treatment-naive, mild RRMS patients. There was 97% consensus to treat highly active RRMS, but no consensus on therapy choice. With RIS, there was consensus not to initiate treatment with brain but no spinal MRI lesions. Current US treatment patterns emphasize MRI in MS diagnosis and subsequent treatment decisions, treatment of early disease, aggressive initial treatment of highly active MS, and close patient monitoring.
authors: Georgetown University Hospital (CT), Washington, DC; Baylor Institute for Immunology Research (JTP), Dallas, TX; Wayne State University School of Medicine (OK), Detroit, MI; Mount Sinai School of Medicine (AEM), New York, NY; and Infusion Communications (CJB), Haddam, CT.
authors: Carlo
authors: C
authors: Tornatore
authors: J Theodore
authors: JT
authors: Phillips
authors: Omar
authors: O
authors: Khan
authors: Aaron E
authors: AE
authors: Miller
authors: Christopher J
authors: CJ
authors: Barnes
references: Neurology. 2011 Jan 4;76(1 Suppl 1):S14-25
references: 21205678
references: Ann Neurol. 2011 Feb;69(2):292-302
references: 21387374
references: Nat Rev Neurol. 2010 Jul;6(7):373-82
references: 20551946
references: Ann Neurol. 2001 Jul;50(1):121-7
references: 11456302
references: Neurology. 2009 Mar 3;72(9):800-5
references: 19073949
references: Clin Neurol Neurosurg. 2001 Apr;103(1):1-11
references: 11311469
references: Lancet Neurol. 2011 Jun;10(6):520-9
references: 21571593
references: Nat Rev Neurol. 2011 Dec 06;8(1):13-21
references: 22143362
references: Arch Neurol. 2005 Jun;62(6):865-70
references: 15956157
references: Mult Scler. 2008 Nov;14(9):1157-74
references: 18805839
references: Neurology. 2010 Feb 2;74(5):427-34
references: 20054006
references: Ann Neurol. 2011 Sep;70(3):520; author reply 521
references: 21710627
references: Neurology. 2011 Feb 22;76(8):686-92
references: 21270417
references: CNS Drugs. 2011 Jan;25(1):37-52
references: 21128693
references: Lancet Neurol. 2007 Aug;6(8):677-86
references: 17616439
references: Acta Neurol Belg. 2011 Jun;111(2):89-98
references: 21748926
references: Brain. 1997 Nov;120 ( Pt 11):2059-69
references: 9397021
references: Expert Opin Pharmacother. 2001 Apr;2(4):623-39
references: 11336612